Pilot randomized trial of hydrocortisone in ventilator-dependent extremely preterm infants: effects on regional brain volumes.

[1]  L. Doyle,et al.  Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. , 2014, The Cochrane database of systematic reviews.

[2]  Steven P. Miller,et al.  Preterm Cerebellar Growth Impairment After Postnatal Exposure to Glucocorticoids , 2011, Science Translational Medicine.

[3]  Ponnada A. Narayana,et al.  Comprehensive Brain MRI Segmentation in High Risk Preterm Newborns , 2010, PloS one.

[4]  K. Watterberg.  Postnatal Corticosteroids to Prevent or Treat Bronchopulmonary Dysplasia , 2010, Pediatrics.

[5]  L. Doyle,et al.  Postnatal Hydrocortisone for Preventing or Treating Bronchopulmonary Dysplasia in Preterm Infants: A Systematic Review , 2010, Neonatology.

[6]  Jessica Dubois,et al.  Brain Development of the Preterm Neonate after Neonatal Hydrocortisone Treatment for Chronic Lung Disease Patients and Methods , 2022 .

[7]  B. Yoder,et al.  Time-Related Changes in Steroid Use and Bronchopulmonary Dysplasia in Preterm Infants , 2009, Pediatrics.

[8]  M. Walsh,et al.  Impact of Postnatal Corticosteroid Use on Neurodevelopment at 18 to 22 Months' Adjusted Age: Effects of Dose, Timing, and Risk of Bronchopulmonary Dysplasia in Extremely Low Birth Weight Infants , 2009, Pediatrics.

[9]  M. Hallman,et al.  Trial of Early Neonatal Hydrocortisone: Two-Year Follow-Up , 2008, Neonatology.

[10]  Simon K Warfield,et al.  Neonate hippocampal volumes: Prematurity, perinatal predictors, and 2‐year outcome , 2008, Annals of neurology.

[11]  K. Hsu,et al.  Effects of Neonatal Corticosteroid Treatment on Hippocampal Synaptic Function , 2007, Pediatric Research.

[12]  D. Grobbee,et al.  Neonatal hydrocortisone treatment: neurodevelopmental outcome and MRI at school age in preterm-born children. , 2007, The Journal of pediatrics.

[13]  Nehal A Parikh,et al.  Postnatal Dexamethasone Therapy and Cerebral Tissue Volumes in Extremely Low Birth Weight Infants , 2007, Pediatrics.

[14]  P. Kamphuis,et al.  Short- and long-term effects of neonatal glucocorticoid therapy: is hydrocortisone an alternative to dexamethasone? , 2007 .

[15]  N. Laforgia,et al.  Early Low-Dose Hydrocortisone in Very Preterm Infants: A Randomized, Placebo-Controlled Trial , 2006, Neonatology.

[16]  L. Doornen,et al.  Differences in Behavioral Outcome and Motor Development at School Age After Neonatal Treatment for Chronic Lung Disease with Dexamethasone versus Hydrocortisone , 2006, Pediatric Research.

[17]  J. Carlin,et al.  Low-Dose Dexamethasone Facilitates Extubation Among Chronically Ventilator-Dependent Infants: A Multicenter, International, Randomized, Controlled Trial , 2006, Pediatrics.

[18]  Deanne K. Thompson,et al.  Object working memory deficits predicted by early brain injury and development in the preterm infant. , 2005, Brain : a journal of neurology.

[19]  F. Lazeyras,et al.  Structural and Functional Brain Development After Hydrocortisone Treatment for Neonatal Chronic Lung Disease , 2005, Pediatrics.

[20]  M. Hallman,et al.  Pretreatment cortisol values may predict responses to hydrocortisone administration for the prevention of bronchopulmonary dysplasia in high-risk infants. , 2005, The Journal of pediatrics.

[21]  L. Doyle,et al.  Impact of Postnatal Systemic Corticosteroids on Mortality and Cerebral Palsy in Preterm Infants: Effect Modification by Risk for Chronic Lung Disease , 2005, Pediatrics.

[22]  K. Watterberg,et al.  Prophylaxis of Early Adrenal Insufficiency to Prevent Bronchopulmonary Dysplasia: A Multicenter Trial , 2004, Pediatrics.

[23]  B. Schmidt,et al.  Impact of Bronchopulmonary Dysplasia, Brain Injury, and Severe Retinopathy on the Outcome of Extremely Low-Birth-Weight Infants at 18 Months: Results From the Trial of Indomethacin Prophylaxis in Preterms , 2003 .

[24]  F. Bel,et al.  Short‐ and long‐term effects of neonatal glucocorticoid therapy: is hydrocortisone an alternative to dexamethasone? , 2003, Acta paediatrica.

[25]  W. Poole,et al.  Adverse effects of early dexamethasone treatment in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. , 2001, The New England journal of medicine.

[26]  K. Watterberg,et al.  Prophylaxis against early adrenal insufficiency to prevent chronic lung disease in premature infants. , 1999, Pediatrics.

[27]  J. Tyson,et al.  A multicenter trial of two dexamethasone regimens in ventilator-dependent premature infants. , 1998, The New England journal of medicine.

[28]  R. Kikinis,et al.  Quantitative magnetic resonance imaging of brain development in premature and mature newborns , 1998, Annals of neurology.

[29]  R. S. Sloviter,et al.  Hippocampal dentate granule cell degeneration after adrenalectomy in the rat is not reversed by dexamethasone , 1995, Brain Research.

[30]  M. Cornblath,et al.  American Academy of Pediatrics. Committee on fetus and newborn. Nomenclature for duration of gestation, birth weight and intra-uterine growth. , 1967, Pediatrics.

[31]  H. Lee.  Growth and Neurodevelopmental Outcomes After Early Low-Dose Hydrocortisone Treatment in Extremely Low Birth Weight Infants , 2008 .

[32]  L. Papile.  Outcome at 2 Years of Age of Infants From the DART Study: A Multicenter, International, Randomized, Controlled Trial of Low-Dose Dexamethasone , 2008 .

[33]  D. Stevenson.  Low-Dose Dexamethasone Facilitates Extubation Among Chronically Ventilator-Dependent Infants: A Multicenter, International, Randomized, Controlled Trial , 2007 .

[34]  M. Bland,et al.  Pulmonary Effects of Triiodothyronine (T3) and Hydrocortisone (HC) Supplementation in Preterm Infants less than 30 Weeks Gestation: Results of the THORN Trial—Thyroid Hormone Replacement in Neonates , 2003, Pediatric Research.

[35]  E. Bancalari,et al.  Bronchopulmonary dysplasia. , 1986, Pediatric clinics of North America.